Shilpi Rajoria

956 total citations
21 papers, 730 citations indexed

About

Shilpi Rajoria is a scholar working on Molecular Biology, Immunology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shilpi Rajoria has authored 21 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shilpi Rajoria's work include Estrogen and related hormone effects (6 papers), Immunotherapy and Immune Responses (6 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). Shilpi Rajoria is often cited by papers focused on Estrogen and related hormone effects (6 papers), Immunotherapy and Immune Responses (6 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). Shilpi Rajoria collaborates with scholars based in United States and Italy. Shilpi Rajoria's co-authors include Robert Suriano, Raj K. Tiwari, Arulkumaran Shanmugam, Andrea L. George, Jan Geliebter, Abraham Mittelman, Stimson P. Schantz, Yushan Lisa Wilson, Margarida Barroso and Lingling Zhao and has published in prestigious journals such as PLoS ONE, Cancer Research and Molecular Cancer.

In The Last Decade

Shilpi Rajoria

20 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shilpi Rajoria United States 12 377 180 140 121 115 21 730
Malcolm A. King Australia 15 468 1.2× 119 0.7× 148 1.1× 57 0.5× 90 0.8× 21 755
Umarani Pugazhenthi United States 13 557 1.5× 354 2.0× 253 1.8× 154 1.3× 82 0.7× 23 958
Jalal A. Jazayeri Australia 15 471 1.2× 21 0.1× 163 1.2× 84 0.7× 104 0.9× 24 779
Stephan Arni Switzerland 22 513 1.4× 76 0.4× 198 1.4× 47 0.4× 216 1.9× 67 1.5k
Pernille Holm Denmark 23 583 1.5× 214 1.2× 109 0.8× 275 2.3× 239 2.1× 33 1.3k
Bobbe L. Ferraiolo United States 12 281 0.7× 86 0.5× 86 0.6× 59 0.5× 221 1.9× 19 688
Lisa M. Chelstrom United States 16 272 0.7× 40 0.2× 181 1.3× 70 0.6× 213 1.9× 33 907
Marynette Rihanek United States 12 403 1.1× 103 0.6× 262 1.9× 180 1.5× 459 4.0× 16 1.0k
W E Grizzle United States 11 352 0.9× 52 0.3× 173 1.2× 258 2.1× 32 0.3× 19 681
M. Kéramidas France 14 318 0.8× 88 0.5× 47 0.3× 54 0.4× 50 0.4× 19 592

Countries citing papers authored by Shilpi Rajoria

Since Specialization
Citations

This map shows the geographic impact of Shilpi Rajoria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilpi Rajoria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilpi Rajoria more than expected).

Fields of papers citing papers by Shilpi Rajoria

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilpi Rajoria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilpi Rajoria. The network helps show where Shilpi Rajoria may publish in the future.

Co-authorship network of co-authors of Shilpi Rajoria

This figure shows the co-authorship network connecting the top 25 collaborators of Shilpi Rajoria. A scholar is included among the top collaborators of Shilpi Rajoria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilpi Rajoria. Shilpi Rajoria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rudkouskaya, Alena, et al.. (2020). Quantitative label-free imaging of iron-bound transferrin in breast cancer cells and tumors. Redox Biology. 36. 101617–101617. 16 indexed citations
2.
George, Andrea L., Robert Suriano, Shilpi Rajoria, et al.. (2015). PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells. Journal of Cancer. 6(12). 1320–1330. 5 indexed citations
3.
Rajoria, Shilpi, Andrea Nicolini, Jan Geliebter, et al.. (2014). Interlinking of Hypoxia and Estrogen in Thyroid Cancer Progression. Current Medicinal Chemistry. 21(11). 1351–1360. 17 indexed citations
4.
Zhao, Lingling, Ken Abe, Shilpi Rajoria, et al.. (2014). Spatial light modulator based active wide-field illumination for ex vivo and in vivo quantitative NIR FRET imaging. Biomedical Optics Express. 5(3). 944–944. 29 indexed citations
5.
Rajoria, Shilpi, Zbigniew Darżynkiewicz, Shihua Zhao, et al.. (2014). Disruption of mutated BRAF signaling modulates thyroid cancer phenotype. BMC Research Notes. 7(1). 187–187. 8 indexed citations
6.
Rajoria, Shilpi, Lingling Zhao, Xavier Intes, & Margarida Barroso. (2014). FLIM-FRET for Cancer Applications. PubMed. 3(2). 144–161. 47 indexed citations
7.
Suriano, Robert, Shilpi Rajoria, Andrea L. George, et al.. (2013). Follow-up analysis of a randomized phase III immunotherapeutic clinical trial on melanoma. Molecular and Clinical Oncology. 1(3). 466–472. 10 indexed citations
8.
Suriano, Robert, Shilpi Rajoria, Andrea L. George, et al.. (2013). Ex Vivo Derived Primary Melanoma Cells: Implications for Immunotherapeutic Vaccines. Journal of Cancer. 4(5). 371–382. 9 indexed citations
9.
George, Andrea L., et al.. (2012). Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence. Molecular Cancer. 11(1). 80–80. 41 indexed citations
10.
Shanmugam, Arulkumaran, Shilpi Rajoria, Andrea L. George, et al.. (2012). Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants. PLoS ONE. 7(2). e30839–e30839. 122 indexed citations
11.
Rajoria, Shilpi, Robert Suriano, Andrea L. George, et al.. (2012). Molecular target based combinational therapeutic approaches in thyroid cancer. Journal of Translational Medicine. 10(1). 81–81. 11 indexed citations
12.
Rajoria, Shilpi, Robert Suriano, Yushan Lisa Wilson, et al.. (2011). 3,3′-Diindolylmethane Modulates Estrogen Metabolism in Patients with Thyroid Proliferative Disease: A Pilot Study. Thyroid. 21(3). 299–304. 37 indexed citations
13.
Rajoria, Shilpi, Robert Suriano, Andrea L. George, et al.. (2011). Estrogen Induced Metastatic Modulators MMP-2 and MMP-9 Are Targets of 3,3′-Diindolylmethane in Thyroid Cancer. PLoS ONE. 6(1). e15879–e15879. 69 indexed citations
14.
Rajoria, Shilpi, Robert Suriano, Andrea L. George, et al.. (2011). Estrogen activity as a preventive and therapeutic target in thyroid cancer. Biomedicine & Pharmacotherapy. 66(2). 151–158. 33 indexed citations
15.
George, Andrea L., Shilpi Rajoria, Robert Suriano, et al.. (2011). Endothelial progenitor cell biology in disease and tissue regeneration. Journal of Hematology & Oncology. 4(1). 24–24. 123 indexed citations
16.
Rajoria, Shilpi, Robert Suriano, Yushan Lisa Wilson, et al.. (2011). Estradiol-mediated tumor neo-vascularization. Oncology Letters. 2(3). 453–457. 7 indexed citations
17.
Shanmugam, Arulkumaran, Robert Suriano, Shilpi Rajoria, et al.. (2011). Identification of PSA peptide mimotopes using phage display peptide library. Peptides. 32(6). 1097–1102. 7 indexed citations
18.
Shanmugam, Arulkumaran, Robert Suriano, Neha Goswami, et al.. (2010). Identification of peptide mimotopes of gp96 using single-chain antibody library. Cell Stress and Chaperones. 16(2). 225–234. 4 indexed citations
19.
Rajoria, Shilpi, Robert Suriano, Arulkumaran Shanmugam, et al.. (2010). Metastatic Phenotype Is Regulated by Estrogen in Thyroid Cells. Thyroid. 20(1). 33–41. 133 indexed citations
20.
Rajoria, Shilpi, Parminder Parmar, Stimson Schantz, et al.. (2008). Significance of estrogen receptor in thyroid cancer: Molecular link of epidemiologic observations. Cancer Research. 68. 4254–4254.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026